Insights

  

Management of Sialorrhea in Parkinson Disease


Richard Trosch, MD, provides a brief overview of sialorrhea and the ideal time for intervention in patients with Parkinson’s disease.  

Pathophysiology, including the different glands and receptors involved that result in sialorrhea.

Experts discuss various strategies along with objective and subjective tools to better recognize and evaluate sialorrhea in patients with PD (Parkinson Disease).

Consequences of sialorrhea and impact on the physical and social quality of life of the patient.

Richard Trosch, MD, discusses the management of sialorrhea with surgical intervention and the adverse effects resulting from oral therapies.

Mechanisms of action and types of botulinum toxic injectables to treat sialorrhea.

Experts discuss the differences between botulinum toxins A and B and present their preferences in using these in their practice.

Comparing accuracy of ultrasound-guided vs anatomical localization of botulinum toxic injections into cadaver salivary glands.

Richard Trosch, MD, provides his view on using ultrasound guidance vs anatomical localizations and the adverse effects resulting from injecting into the glands.

Stuart Isaacson, MD, discusses the strategies of dose escalation and gauging response when injecting patients with botulinum toxic substances.

Experts discuss practical considerations and logistics involved in the treatment of sialorrhea with botulinum toxic injections.

Expert panelists provide advice to neurologists to incorporate the use of botulinum toxic injections into their practice to treat sialorrhea in PD.
SAP Partner Banner